{
    "organizations": [],
    "uuid": "fd6b2453d1e5ef4590d9fd2d3cd37ed6008c3cda",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cannimed-signs-letter-of-intent-wi/brief-cannimed-signs-letter-of-intent-with-pharmasave-idUSFWN1RH0E5",
    "ord_in_thread": 0,
    "title": "BRIEF-Cannimed Signs Letter Of Intent With Pharmasave",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 4 (Reuters) - CanniMed Therapeutics Inc:\n* CANNIMED SIGNS LETTER OF INTENT WITH PHARMASAVE * CANNIMED HAS ENTERED INTO A LETTER OF INTENT TO BECOME PREFERRED SUPPLIER OF MEDICAL CANNABIS TO PHARMASAVE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-04T19:31:00.000+03:00",
    "crawled": "2018-04-05T17:25:55.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "cannimed",
        "therapeutic",
        "inc",
        "cannimed",
        "sign",
        "letter",
        "intent",
        "pharmasave",
        "cannimed",
        "entered",
        "letter",
        "intent",
        "become",
        "preferred",
        "supplier",
        "medical",
        "cannabis",
        "pharmasave",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}